title: Medicine. A portfolio model of drug development for tuberculosis.
authors.affiliation: Health Sector Management Program, Fuqua School of Business, Duke University, Durham, NC 27708, USA.
authors.forename: Seth W
authors.initials: SW
authors.lastname: Glickman
authors.forename: Emma B
authors.initials: EB
authors.lastname: Rasiel
authors.forename: Carol Dukes
authors.initials: CD
authors.lastname: Hamilton
authors.forename: Arsen
authors.initials: A
authors.lastname: Kubataev
authors.forename: Kevin A
authors.initials: KA
authors.lastname: Schulman
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000191:economics; D003198:Computer Simulation; D003365:Costs and Cost Analysis; D017277:Drug Approval / Q000191:economics; D004353:Drug Evaluation, Preclinical / Q000191:economics; D004345:Drug Industry; D006801:Humans; D009010:Monte Carlo Method; D009316:National Institutes of Health (U.S.); D017149:Private Sector; D011336:Probability; D017150:Public Sector; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy*; D014481:United States
chemical_list: D000995:Antitubercular Agents